The Effect of Electroacustimulation on Postoperative Nausea, Vomiting and Pain in Outpatient Plastic Surgery Patients
1 other identifier
interventional
122
1 country
1
Brief Summary
Introduction: Current rates of postoperative nausea and vomiting (PONV) experienced by outpatient surgery patients are as high as 20-30%. Electroacustimulation (EAS) therapy has been demonstrated to be effective in controlling these symptoms, but trials identifying their efficacy in the outpatient surgery population are lacking. This study integrates conventional pharmacotherapy with alternative medicine in prevention of PONV. Materials and Methods: One hundred twenty two patients undergoing surgery procedures at an outpatient surgery center were randomized to two treatment arms. The first arm was standardized pharmacologic PONV prevention typical for patients undergoing outpatient surgery, while the second arm employed the use of ReliefBand, an FDA-approved electroacustimulation (EAS) device with pharmacologic treatment to relieve symptoms of PONV and pain. EAS is a derivative of acupuncture therapy that uses a small electrical current to stimulate acupuncture points on the human body and is thought to relieve nausea, vomiting and pain. Outcomes measured were post-op questionnaires evaluating pain and nausea symptoms, emetic events, the need for rescue medications and the time to discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 15, 2009
CompletedFirst Posted
Study publicly available on registry
July 17, 2009
CompletedResults Posted
Study results publicly available
August 25, 2020
CompletedAugust 25, 2020
August 1, 2020
11 months
July 15, 2009
July 28, 2020
August 12, 2020
Conditions
Outcome Measures
Primary Outcomes (5)
Post-operative Nausea Scores
Nausea is scored on a scale of 1-10 where 1 is least nauseated and 10 is severely nauseated. Nausea scores will be collected 30, 60, and 120 minutes after surgery.
24 hours
Incidence of Post-operative Emetic Events
24 hours
Number of Participants With Post-operative Need for Rescue Medications
24 hours
Time to Participant Discharge
24 hours
Phone Survey of Nausea / Vomiting Symptoms 24 Hours Post-op
Phone survey of nausea/vomiting symptoms was administered on postoperative day 1. The survey consists of 8 questions, including: 1) a query about whether or not participant has experienced nausea since returning home; 2) rate nausea severity on a scale of 1-10 (where 10 is the most severe); 3) a query about satisfaction of nausea control; 4) a question asking if they would use the same post-op nausea treatment again; 5) a query about what activities the participant has been unable to do since surgery; 6) whether or not the participant has taken prescription medicine for treatment of nausea since returning home; 7) whether or not participant has taken prescription medicine for treatment of pain since returning home; and 8) if yes for 6-7, which medications.
24 hours post-op
Secondary Outcomes (2)
Postoperative Pain Scores
24 hours
Number of Participants Who Took Pain Medicine in the First 24 Hours Post-op
24 hours post-op
Study Arms (2)
Electroacustimulation
EXPERIMENTALReceived electroacustimulation at the wrist using a small, battery-powered electroacustimulation device.
Control
SHAM COMPARATORReceived a device that was not turned on.
Interventions
Electroacustimulation (EAS) is a derivative form of acupuncture therapy where a small current of electricity instead of a needle is used to stimulate an acupoint on the human body in an effort to create therapeutic effects.
Eligibility Criteria
You may qualify if:
- undergoing surgery at the University of Wisconsin outpatient surgery center
You may not qualify if:
- pregnancy
- currently experiencing menstrual symptoms
- cardiac pacemaker
- previous experience with acupuncture therapy
- pharmacologic treatment for nausea or vomiting in the 24 hours prior to surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Transformations Surgery Center
Middleton, Wisconsin, 53719, United States
Related Publications (2)
Gan TJ, Jiao KR, Zenn M, Georgiade G. A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting. Anesth Analg. 2004 Oct;99(4):1070-1075. doi: 10.1213/01.ANE.0000130355.91214.9E.
PMID: 15385352BACKGROUNDLarson JD, Gutowski KA, Marcus BC, Rao VK, Avery PG, Stacey DH, Yang RZ. The effect of electroacustimulation on postoperative nausea, vomiting, and pain in outpatient plastic surgery patients: a prospective, randomized, blinded, clinical trial. Plast Reconstr Surg. 2010 Mar;125(3):989-94. doi: 10.1097/PRS.0b013e3181ccdc23.
PMID: 20195124RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Raw data from which to report summary results no longer exist for this study. Outcomes were published and the data were represented in graphs. We have done our due diligence to populate this record with data provided in the publication.
Results Point of Contact
- Title
- Jeffrey Larson, MD
- Organization
- University of Wisconsin - Madison
Study Officials
- PRINCIPAL INVESTIGATOR
Karol A Gutowski, MD
Endeavor Health
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2009
First Posted
July 17, 2009
Study Start
January 1, 2008
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
August 25, 2020
Results First Posted
August 25, 2020
Record last verified: 2020-08